FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017059360> ?p ?o ?g. }

• W3017059360 endingPage "1082" @default.
• W3017059360 startingPage "1071" @default.
• W3017059360 abstract "The purpose of this study was to evaluate clinical and echocardiographic outcome data of the CHOICE (Randomized Comparison of Transcatheter Heart Valves in High Risk Patients with Severe Aortic Stenosis: Medtronic CoreValve Versus Edwards SAPIEN XT) trial at 5 years. The CHOICE trial was designed to compare device performance of a balloon-expandable (BE) transcatheter heart valve (THV) versus a self-expanding (SE) THV. The CHOICE trial is an investigator-initiated trial that randomized 241 high-risk patients with severe symptomatic aortic stenosis and an anatomy suitable for treatment with both BE and SE THVs to transfemoral transcatheter aortic valve replacement with either device. The primary endpoint was device success. Patients were followed up to 5 years, with assessment of clinical outcomes, and echocardiographic evaluation of valve function and THV durability. After 5 years, there were no statistically significant differences between BE and SE valves in the cumulative incidence of death from any cause (53.4% vs. 47.6%; p = 0.38), death from cardiovascular causes (31.6% vs. 21.5%; p = 0.12), all strokes (17.5% vs. 16.5%; p = 0.73), and repeat hospitalization for heart failure (28.9% vs. 22.5%; p = 0.75). SE patients had larger prosthetic valve area (1.6 ± 0.5 cm2 vs. 1.9 ± 0.5 cm2; p = 0.02) with a lower mean transprosthetic gradient (12.2 ± 8.7 mm Hg vs. 6.9 ± 2.7 mm Hg; p = 0.001) at 5 years. No differences were observed in the rates of paravalvular regurgitation. Clinical valve thrombosis occurred in 7 BE patients (7.3%) and 1 SE patient (0.8%; p = 0.06), and moderate or severe structural valve deterioration in 6 BE patients (6.6%) and no SE patient (0%; p = 0.018). The rate of bioprosthetic valve failure was low and not significantly different between both groups (4.1% vs. 3.4%; p = 0.63). Five-year follow-up of patients in the CHOICE trial revealed clinical outcomes after transfemoral transcatheter aortic valve replacement with early-generation BE and SE valves that were not statistically significantly different, with limited statistical power. Forward flow hemodynamics were significantly better with the SE valve. Moderate or severe structural valve deterioration was uncommon but occurred more frequently with the BE valve. (A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial [CHOICE]; NCT01645202)" @default.
• W3017059360 created "2020-04-24" @default.
• W3017059360 creator A5007093669 @default.
• W3017059360 creator A5009941985 @default.
• W3017059360 creator A5024507851 @default.
• W3017059360 creator A5027390338 @default.
• W3017059360 creator A5027761933 @default.
• W3017059360 creator A5034537373 @default.
• W3017059360 creator A5039377663 @default.
• W3017059360 creator A5041156105 @default.
• W3017059360 creator A5053432210 @default.
• W3017059360 creator A5057534153 @default.
• W3017059360 creator A5077653018 @default.
• W3017059360 creator A5077992244 @default.
• W3017059360 creator A5085109663 @default.
• W3017059360 creator A5086697658 @default.
• W3017059360 creator A5089531887 @default.
• W3017059360 date "2020-05-01" @default.
• W3017059360 modified "2023-10-18" @default.
• W3017059360 title "5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves" @default.
• W3017059360 cites W1447151910 @default.
• W3017059360 cites W154292533 @default.
• W3017059360 cites W1970667076 @default.
• W3017059360 cites W2022123127 @default.
• W3017059360 cites W2025402871 @default.
• W3017059360 cites W2037507673 @default.
• W3017059360 cites W2107912271 @default.
• W3017059360 cites W2132585880 @default.
• W3017059360 cites W2165258820 @default.
• W3017059360 cites W2166973706 @default.
• W3017059360 cites W2324073140 @default.
• W3017059360 cites W2596188051 @default.
• W3017059360 cites W2596770251 @default.
• W3017059360 cites W2604699171 @default.
• W3017059360 cites W2626331509 @default.
• W3017059360 cites W2737109842 @default.
• W3017059360 cites W2756767487 @default.
• W3017059360 cites W2795803030 @default.
• W3017059360 cites W2804943459 @default.
• W3017059360 cites W2884605701 @default.
• W3017059360 cites W2901144728 @default.
• W3017059360 cites W2901172024 @default.
• W3017059360 cites W2902598843 @default.
• W3017059360 cites W2911992158 @default.
• W3017059360 cites W2921388585 @default.
• W3017059360 cites W2922215374 @default.
• W3017059360 cites W2938485399 @default.
• W3017059360 cites W2979362489 @default.
• W3017059360 cites W323864819 @default.
• W3017059360 cites W751610616 @default.
• W3017059360 cites W2932126574 @default.
• W3017059360 doi "https://doi.org/10.1016/j.jcin.2019.12.026" @default.
• W3017059360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32305398" @default.
• W3017059360 hasPublicationYear "2020" @default.
• W3017059360 type Work @default.
• W3017059360 sameAs 3017059360 @default.
• W3017059360 citedByCount "107" @default.
• W3017059360 countsByYear W30170593602020 @default.
• W3017059360 countsByYear W30170593602021 @default.
• W3017059360 countsByYear W30170593602022 @default.
• W3017059360 countsByYear W30170593602023 @default.
• W3017059360 crossrefType "journal-article" @default.
• W3017059360 hasAuthorship W3017059360A5007093669 @default.
• W3017059360 hasAuthorship W3017059360A5009941985 @default.
• W3017059360 hasAuthorship W3017059360A5024507851 @default.
• W3017059360 hasAuthorship W3017059360A5027390338 @default.
• W3017059360 hasAuthorship W3017059360A5027761933 @default.
• W3017059360 hasAuthorship W3017059360A5034537373 @default.
• W3017059360 hasAuthorship W3017059360A5039377663 @default.
• W3017059360 hasAuthorship W3017059360A5041156105 @default.
• W3017059360 hasAuthorship W3017059360A5053432210 @default.
• W3017059360 hasAuthorship W3017059360A5057534153 @default.
• W3017059360 hasAuthorship W3017059360A5077653018 @default.
• W3017059360 hasAuthorship W3017059360A5077992244 @default.
• W3017059360 hasAuthorship W3017059360A5085109663 @default.
• W3017059360 hasAuthorship W3017059360A5086697658 @default.
• W3017059360 hasAuthorship W3017059360A5089531887 @default.
• W3017059360 hasBestOaLocation W30170593601 @default.
• W3017059360 hasConcept C126322002 @default.
• W3017059360 hasConcept C139059822 @default.
• W3017059360 hasConcept C141071460 @default.
• W3017059360 hasConcept C164705383 @default.
• W3017059360 hasConcept C168563851 @default.
• W3017059360 hasConcept C203092338 @default.
• W3017059360 hasConcept C2776229121 @default.
• W3017059360 hasConcept C2778198053 @default.
• W3017059360 hasConcept C2780007028 @default.
• W3017059360 hasConcept C2780026749 @default.
• W3017059360 hasConcept C2780168065 @default.
• W3017059360 hasConcept C2781414266 @default.
• W3017059360 hasConcept C2911091166 @default.
• W3017059360 hasConcept C71924100 @default.
• W3017059360 hasConcept C88879693 @default.
• W3017059360 hasConceptScore W3017059360C126322002 @default.
• W3017059360 hasConceptScore W3017059360C139059822 @default.
• W3017059360 hasConceptScore W3017059360C141071460 @default.
• W3017059360 hasConceptScore W3017059360C164705383 @default.
• W3017059360 hasConceptScore W3017059360C168563851 @default.

• next